Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 3,401–3,408 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Prothena Corporation plc Prasinezumab (PRX002) Parkinson's disease Phase 3 Ongoing Intravenous Neurology
Prothena Corporation plc NEOD001 PRONTO Previously-treated patients with AL amyloidosis and persistent cardiac dysfunction Phase 2b Trial Discontinued Intravenous Cardiology
Prothena Corporation plc BMS-986446 (PRX005) - (TargetTau-1) Alzheimer’s disease Phase 2 Ongoing Intravenous Neurology
Psyence Biomedical Ltd. Psilocybin (NPX5) Adjustment Disorder due to a recent cancer diagnosis Phase 2b Enrollment Initiation Oral Psychiatric
Psyence Biomedical Ltd. CLA-PSY-201 Alcohol Use Disorder (AUD) Phase 2b Ongoing Oral Psychiatric
PTC Therapeutics Inc. Translarna (ataluren) - (041) Duchenne muscular dystrophy caused by nonsense mutations (nmDMD) PDUFA Ongoing Oral Genetic Disorder
PTC Therapeutics Inc. Upstaza Gene therapy BLA Filing Trial Planned Intracerebral Genetic Disorder
PTC Therapeutics Inc. Translarna Nonsense mutation cystic fibrosis Phase 3 Trial Discontinued Oral Genetic Disorder
1…424425426427428…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.